- Home
- GILD vs UNP Comparison
GILD vs UNP Comparison
Compare GILD & UNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- UNP
- Stock Information
- Founded
- GILD 1987
- UNP 1862
- Country
- GILD United States
- UNP United States
- Employees
- GILD N/A
- UNP N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- UNP Railroads
- Sector
- GILD Health Care
- UNP Industrials
- Exchange
- GILD Nasdaq
- UNP Nasdaq
- Market Cap
- GILD 138.7B
- UNP 130.8B
- IPO Year
- GILD 1992
- UNP N/A
- Fundamental
- Price
- GILD $110.17
- UNP $228.55
- Analyst Decision
- GILD Buy
- UNP Buy
- Analyst Count
- GILD 24
- UNP 23
- Target Price
- GILD $110.95
- UNP $255.43
- AVG Volume (30 Days)
- GILD 6.3M
- UNP 3.0M
- Earning Date
- GILD 08-07-2025
- UNP 07-24-2025
- Dividend Yield
- GILD 2.87%
- UNP 2.34%
- EPS Growth
- GILD 1118.07
- UNP 6.03
- EPS
- GILD 4.73
- UNP 11.10
- Revenue
- GILD $28,735,000,000.00
- UNP $24,246,000,000.00
- Revenue This Year
- GILD $1.69
- UNP $2.38
- Revenue Next Year
- GILD $3.67
- UNP $4.31
- P/E Ratio
- GILD $23.29
- UNP $20.65
- Revenue Growth
- GILD 4.68
- UNP 0.63
- 52 Week Low
- GILD $70.78
- UNP $204.66
- 52 Week High
- GILD $119.96
- UNP $258.07
- Technical
- Relative Strength Index (RSI)
- GILD 51.17
- UNP 49.30
- Support Level
- GILD $107.75
- UNP $222.34
- Resistance Level
- GILD $110.90
- UNP $240.74
- Average True Range (ATR)
- GILD 2.31
- UNP 3.47
- MACD
- GILD -0.38
- UNP -1.21
- Stochastic Oscillator
- GILD 33.99
- UNP 37.17
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the US, Union Pacific generated $24 billion of revenue in 2024 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.